ChristopherCoyneMD

Endocrinology • Worcester, MA

Diabetes, Lipid Metabolism, Thyroid

Physician

Join to view full profile

Dr. Coyne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Coyne's full profile

Already have an account?

Office
55 Lake Ave N

Worcester, MA 01655
Phone+1 508-856-6244

Fax+1 508-856-6950
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1997 - 2000
David Geffen School of Medicine at UCLAClass of 1997

Certifications & Licensure

CA State Medical License 1999 - Present
MA State Medical License 2016 - 2025
PA State Medical License 2007 - 2016
NJ State Medical License 2002 - 2009
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Publications & Presentations

PubMed

38 citations
Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department
Christopher J. Coyne, Vivian Le, Jesse J. Brennan, Edward M. Castillo, Rebecca Shatsky, Karen Ferran, Stephanie K. Brodine, Gary M. Vilke> ;Annals of Emergency Medicine. 2017 Jun 1
Influenza in the Emergency Department: Vaccination, Diagnosis, and Treatment.
Coyne CJ, Abraham MK, Perkins J, Vilke GM> ;J Emerg Med. 2016-12-01
Clinical Guidelines for the Emergency Department Evaluation of Subarachnoid Hemorrhage
Gary M Vilke, Christopher J Coyne, William J Meurer> ;The Journal of Emergency Medicine. 2016 Jan 30
6 citations
Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements
Akeesha A Shah, N. Paul Ohori, Linwah Yip, Christopher Coyne, Cristina R. Antonescu, Raja R. Seethala> ;Endocrine Pathology. 2016 Mar 30
73 citations
Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAFK601E Mutation
Michelle Afkhami, Arivarasan Karunamurthy, Simion I. Chiosea, Marina N. Nikiforova, Raja R. Seethala, Yuri E. Nikiforov, Christopher Coyne> ;Thyroid. 2016 Feb 8
Influenza in the Emergency Department: Vaccination, Diagnosis, and Treatment: Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guide...
Gary M Vilke, Christopher J Coyne, Michael K Abraham> ;The Journal of Emergency Medicine. 2016 Jan 15
268 citations
Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of...
Yuri E. Nikiforov, Sally E. Carty, Simon I. Chiosea, Christopher Coyne, Umamaheswar Duvvuri, Robert L. Ferris, William E. Gooding, Shane O. LeBeau, N. Paul Ohori, Raja...> ;Thyroid. 2015 Nov 6
Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
Yip L, Nikiforova MN, Yoo JY, McCoy KL, Stang MT, Armstrong MJ, Nicholson KJ, Ohori NP, Coyne C, Hodak SP, Ferris RL, LeBeau SO, Nikiforov YE, Carty SE> ;Ann. Surg.. 2015-09-01
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing...
Nikiforov, Y. E.,Carty, S. E.,Chiosea, S. I.,Coyne, C.,Duvvuri, U.,Ferris, R. L.,Gooding, W. E.,Hodak, S. P.,LeBeau, S. O.,Ohori, N. P.,Seethala, R. R.,Tublin, M. E.,Y...> ;Cancer. 2014 Sep 12
A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.
Yip L, Wharry LI, Armstrong MJ, Silbermann A, McCoy KL, Stang MT, Ohori NP, LeBeau SO, Coyne C, Nikiforova MN, Bauman JE, Johnson JT, Tublin ME, Hodak SP, Nikiforov YE...> ;Ann. Surg.. 2014-07-01
A novel mutation in the succinate dehydrogenase subunit D gene in siblings with the hereditary paraganglioma–pheochromocytoma syndrome
Chaithra Prasad, Gerard J. Oakley, Linwah Yip, Christopher Coyne, Balasubramanya Rangaswamy, Sanjay B Dixit> ;SAGE Open Medical Case Reports. 2014 Jan 1
26 citations
Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology
Rohtesh S. Mehta, Sally E. Carty, N. Paul Ohori, Steven P. Hodak, Christopher Coyne, Shane O. LeBeau, Mitchell Tublin, Michael T. Stang, Jonas T. Johnson, Kelly L. McC...> ;Surgery. 2013 Oct 1
61 citations
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
N. Paul Ohori, Rashi L. Singhal, Marina N. Nikiforova, Linwah Yip, Karen E. Schoedel, Christopher Coyne, Kelly L. McCoy, Shane O. LeBeau, Steven P. Hodak, Sally E. Car...> ;Cancer Cytopathology. 2013 Apr 1
RAS Mutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers
Marina N Nikiforova, Michael T Stang, R Seethala, Sally E Carty, Nikhil Gupta, Anil K Dasyam, N Paul Ohori, Linwah Yip, Jonas Johnson, Robert L Ferris, Shane O Lebeau,...> ;Endocrine Society. 2013 May
98 citations
A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.
Leo A. Niemeier, Haruko Kuffner Akatsu, Chi Song, Sally E. Carty, Steven P. Hodak, Linwah Yip, Robert L. Ferris, George C. Tseng, Raja R. Seethala, Shane O. LeBeau, Mi...> ;Cancer. 2012 Apr 15
533 citations
Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples
Yuri E. Nikiforov, N. Paul Ohori, Steven P. Hodak, Sally E. Carty, Shane O. LeBeau, Robert L. Ferris, Linwah Yip, Raja R. Seethala, Mitchell Tublin, Michael T. Stang, ...> ;The Journal of Clinical Endocrinology and Metabolism. 2011 Aug 31
52 citations
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.
Gina M. Howell, Sally E. Carty, Michaele J. Armstrong, Shane O. LeBeau, Steven P. Hodak, Christopher Coyne, Michael T. Stang, Kelly L. McCoy, Marina N. Nikiforova, Yur...> ;Annals of Surgical Oncology. 2011 May 19
Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SK...
Coyne, C. P.,Jones, T.,Pharr, T.> ;Bioorg. Med. Chem.. 2010 Dec 21
RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.
Coyne, C.,Nikiforov, Y. E.> ;Endocr. Pathol.. 2009 Nov 10
Dual potency anti-HER2/neu and anti-EGFR anthracycline immunoconjugates in chemotherapeutic-resistant mammary carcinoma combined with cyclosporin A and verapamil P-gly...
Coyne, C. P.,Ross, M. K.,Bailey, J. G.> ;J Drug Target. 2009 Jun 02
Construction and characterization of two bacterial artificial chromosome libraries of pea (Pisum sativum L.) for the isolation of economically important genes.
Coyne, C. J.,McClendon, M. T.,Walling, J. G.,Timmerman-Vaughan, G. M.,Murray, S.,Meksem, K.,Lightfoot, D. A.,Shultz, J. L.,Keller, K. E.,Martin, R. R.,Inglis, D. A.,Ra...> ;Genome. 2007 Sep 26
Join now to see all

Hospital Affiliations

UMass Memorial Medical CenterWorcester, Massachusetts